Kidney cancer, Renal cell cancer
Results
Phase 2
This trial looked at pazopanib before surgery for kidney cancer that had spread elsewhere in the body. It was for people:
with a type of kidney cancer called clear cell kidney cancer
who hadn’t had treatment for advanced kidney cancer
Recruitment start: 6 July 2010
Recruitment end: 31 August 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Thomas Powles
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
Queen Mary University of London
Last reviewed: 22 Feb 2017
CRUK internal database number: 7655
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
